receptor antagonist candidate being developed for the treatment of classic CAH and ACTH-dependent Cushing’s syndrome. “These exciting results show atumelnant not only lowered key biomarkers ...

OppFi, Corcept Therapeutics, DXP Enterprises, Perpetua Resources and Graham are part of the Zacks Screen of the Week article.

What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...

Brain surgery, like rocket science, has become a byword in popular culture for an intellectually challenging and risky ...

Corcept Therapeutics' long-term goal is $3 billion revenue by 2029, driven by the new drug Relacorilant. Click here to read ...

Record numbers of people are now living with cancer in the UK. New figures show there will be 3.4 million people with the disease in 2025 - the highest level ever reported. Cancer support charity ...

From far-right conspiracy theorists to long-term political advisors, Trump has surrounded himself with a number of vocal Jewish supporters Miriam Adelson, Israeli widow of billionaire casino ...

This is my first year and first time ever making six figures,” she says. Wester is committed to sharing the wealth; every time she earns a commission when someone buys a product through her ...

Scientists are unraveling the mystery of what triggers Huntington’s disease, a devastating hereditary disorder that strikes in the prime of life Scientists are unraveling the mystery of what ...

Inflammatory bowel disease (IBD) is a group of intestinal disorders that cause prolonged inflammation of the digestive tract. It can include ulcerative colitis (UC) or Crohn’s disease.

About 23,690 new cases of CLL (14,340 in males and 9,350 in females) About 4,460 deaths from CLL ( 2,810 in males and 1,650 in females) CLL accounts for about 1 in 3 new cases of leukemia in the US, ...

The study leaders share their findings and what makes them compelling and meaningful. Video: Broad Institute of MIT and Harvard At a glance: Study explains long-standing question of why Huntington’s ...